{"id":"W2891872117","doi":"10.1186/s12894-018-0387-7","title":"Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials","year":2018,"lang":"en","type":"article","venue":"BMC Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Astellas Pharma; Clovis Oncology; Genomic Health; Amgen; Pfizer; Augmenix; Sanofi","keywords":"Bicalutamide; Medicine; Enzalutamide; Prostate cancer; Oncology; Internal medicine; Prostate-specific antigen; Progression-free survival; Hazard ratio; Urology; Confidence interval; Cancer; Chemotherapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01758048,0.0009702487,0.003635912,0.0006408014,0.0001633486,0.0009059384,0.0008459198,0.000844049,0.002282417],"category_scores_gemma":[0.01906001,0.000350869,0.008739033,0.0006072489,0.0005832546,0.00104733,0.0007005205,0.002074194,0.00017507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008328707,"about_ca_system_score_gemma":0.0009218498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003137648,"about_ca_topic_score_gemma":0.0006107652,"domain_scores_codex":[0.9841965,0.01321237,0.000785751,0.0006635882,0.0009012091,0.0002406371],"domain_scores_gemma":[0.9885418,0.008199465,0.002084338,0.0004673668,0.0003586974,0.0003483189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8217022,0.001707087,0.02624695,0.00694912,0.05242264,0.0001787351,0.0002015165,0.02799969,0.002585336,0.002009648,0.002882571,0.05511455],"study_design_scores_gemma":[0.5297336,0.2291046,0.09044369,0.001624111,0.04970227,0.0009044721,0.0002372762,0.06108212,0.004680893,0.009792453,0.02243861,0.0002558915],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9334325,0.02987096,0.01641296,0.001136228,0.0004931191,0.007344942,0.004168294,0.0001706821,0.006970315],"genre_scores_gemma":[0.9811285,0.002535559,0.006043109,0.0005566878,0.0001014426,0.006035688,0.002350782,0.00003515732,0.001213243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01758048,"threshold_uncertainty_score":0.09297556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09198609631662609,"score_gpt":0.4681050233197285,"score_spread":0.3761189270031025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}